Logo image of ACEV

ACE CONVERGENCE ACQU-CLASS A (ACEV) Stock Fundamental Analysis

NASDAQ:ACEV - Nasdaq - KYG0083D1209 - Common Stock - Currency: USD

9.78  +0.64 (+7%)

After market: 9.7 -0.08 (-0.82%)

Fundamental Rating

2

Overall ACEV gets a fundamental rating of 2 out of 10. We evaluated ACEV against 0 industry peers in the Unkown industry. The financial health of ACEV is average, but there are quite some concerns on its profitability. ACEV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ACEV had positive earnings in the past year.
In the past year ACEV has reported a negative cash flow from operations.
ACEV Yearly Net Income VS EBIT VS OCF VS FCFACEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 0 5M -5M

1.2 Ratios

Industry RankSector Rank
ROA 32.93%
ROE 43.17%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACEV Yearly ROA, ROE, ROICACEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 2 -2 -4

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ACEV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACEV Yearly Profit, Operating, Gross MarginsACEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for ACEV remains at a similar level compared to 1 year ago.
Compared to 1 year ago, ACEV has a worse debt to assets ratio.
ACEV Yearly Shares OutstandingACEV Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 5M 10M 15M 20M 25M
ACEV Yearly Total Debt VS Total AssetsACEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 3.37 indicates that ACEV is not in any danger for bankruptcy at the moment.
ACEV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.37
ROIC/WACCN/A
WACCN/A
ACEV Yearly LT Debt VS Equity VS FCFACEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.00 indicates that ACEV may have some problems paying its short term obligations.
ACEV has a Quick Ratio of 0.00. This is a bad value and indicates that ACEV is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
ACEV Yearly Current Assets VS Current LiabilitesACEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2M 4M 6M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 272.64% over the past year.
EPS 1Y (TTM)272.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2103.16%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACEV Yearly Revenue VS EstimatesACEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021
ACEV Yearly EPS VS EstimatesACEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.47, the valuation of ACEV can be described as very cheap.
The average S&P500 Price/Earnings ratio is at 29.62. ACEV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.47
Fwd PE N/A
ACEV Price Earnings VS Forward Price EarningsACEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACEV Per share dataACEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ACEV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACE CONVERGENCE ACQU-CLASS A

NASDAQ:ACEV (11/22/2022, 8:00:00 PM)

After market: 9.7 -0.08 (-0.82%)

9.78

+0.64 (+7%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.27%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap136.45M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.47
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.14
P/tB 2.14
EV/EBITDA N/A
EPS(TTM)1.31
EY13.39%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS4.56
TBVpS4.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 32.93%
ROE 43.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z 3.37
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)272.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2103.16%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-119.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-115.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-115.05%
OCF growth 3YN/A
OCF growth 5YN/A